The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …

Crohn's disease and ulcerative colitis have emerged as global diseases. They affect over 2
million individuals in the North America, 3.2 million in Europe, and millions more worldwide …

Inflammatory bowel disease (IBD) affects millions of people each year. The overproduction
of reactive oxygen species (ROS) plays a critical role in the progress of IBD and will be a …

A key challenge for the effective treatment of gastrointestinal diseases including
inflammatory bowel disease is to develop an orally administered drug delivery system …

The inflammatory bowel diseases ulcerative colitis and Crohn's disease are chronic,
relapsing disorders of the gastrointestinal tract. Collectively, these conditions can result in …

Background & Aims Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory
disorder associated with an elevated risk of colorectal cancer (CRC). IBD-associated CRC …

Inflammatory bowel disease (IBD) is an inflammatory disease of the gastrointestinal tract, the
incidence of which has rapidly increased worldwide, especially in developing and Western …

Inflammatory bowel diseases (IBD) are chronic medical disorders characterized by recurrent
gastrointestinal inflammation. While the etiology of IBD is still unknown, the pathogenesis of …

Background Human umbilical cord mesenchymal stem cell (hucMSC)-derived exosomes
are recognized as novel cell-free therapeutic agents for inflammatory bowel disease (IBD), a …

Mitochondria serve numerous critical cellular functions, rapidly responding to extracellular
stimuli and cellular demands while dynamically communicating with other organelles …